Amy E. Tapper - 03 Jan 2023 Form 4 Insider Report for Imago BioSciences, Inc.

Reporting relationship: Officer
Issuer ticker: N/A
Reported as of: 03 Jan 2023
Net transaction value: +$102,321
SEC form: 4
Accepted by SEC: 05 Jan 2023, 15:28:23 UTC
Prior SEC filing: 20 Dec 2022
Next SEC filing: 11 Jan 2023
Source filing: View source filing
Reporting owner signature: /s/ Hugh Rienhoff, as Attorney-in-Fact for Amy E. Tapper

Key filing fact

Amy E. Tapper filed Form 4 for Imago BioSciences, Inc. on 05 Jan 2023.

Key facts

This page summarizes Amy E. Tapper's Form 4 filing for Imago BioSciences, Inc..
6 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 05 Jan 2023, 15:28.

Change

Previous filing in this sequence was filed on 20 Dec 2022.
Current net transaction value: +$102,321.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMGO transaction

Common Stock

Options Exercise

Transaction value: $18,855
Shares: +7,482
Change %: +6.2%
Price: $2.52^*
Shares after: 127,315
Date: 03 Jan 2023
Ownership: Direct
Footnotes: F1

IMGO transaction

Common Stock

Options Exercise

Transaction value: $52,080
Shares: +12,400
Change %: +9.7%
Price: $4.20^*
Shares after: 139,715
Date: 03 Jan 2023
Ownership: Direct

IMGO transaction

Common Stock

Options Exercise

Transaction value: $31,386
Shares: +1,379
Change %: +0.99%
Price: $22.76
Shares after: 141,094
Date: 03 Jan 2023
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMGO transaction Derivative

Stock Option (Right to buy)

Options Exercise

Transaction value: $0
Shares: -7,482
Change %: -91%
Price: $0.000000
Shares after: 750
Date: 03 Jan 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,482
Exercise price: $2.52

IMGO transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -12,400
Change %: -52%
Price: $0.000000
Shares after: 11,409
Date: 03 Jan 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,400
Exercise price: $4.20
Footnotes: F2

IMGO transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -1,379
Change %: -1.5%
Price: $0.000000
Shares after: 90,121
Date: 03 Jan 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,379
Exercise price: $22.76
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Reflects the adjusted total which includes the purchase of 786 shares under the Imago Employee Stock Purchase Plan on November 30, 2022.

Footnote F2

One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from November 12, 2020 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

Footnote F3

25% of the shares subject to the option vest on the first anniversary measured from November 17, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.